Pan-Ethnic Carrier Screen Development
Your Development. Our Platform.
The TessArae Pan-Ethnic Carrier Screening panel was developed with the Emory Genetics Laboratory (EGL), a leading academic laboratory providing superior cutting-edge genetic testing. This custom assay simultaneously screens for the presence of over 460 known mutations in over 80 different disorders.
Partnering with TessArae accelerates your development of a turnkey Carrier Screening Assay that truly delivers.
Fast From extracted sample to a gene-by-gene, locus-by-locus list of detected mutations in less than 24 hours. TessArae enables the development of the fastest multiplexed sequencing assays available today.
Precise The DNA sequence is provided at each locus – indicating wildtype or mutant, and heterozygous or homozygous. Sophisticated confidence metrics give you the accuracy you need.
Comprehensive The assay detects numerous mutations in disorders with high carrier rates in many different ethnic backgrounds, including Beta-Thalassemia and Sickle Cell Disease, Pompe Disease, Cystic Fibrosis, Wilson Disease, PKU, MCAD, ARPKD, HFI, FMF, Tay-Sachs Disease, Gaucher Disease, Familial Dysautonomia, Canavan Disease, and many others. See the mutations and genes in over 80 inherited disorders, all detected in the same assay.
Validated At the 2011 ACMG Conference, EGL presented results from carrier screening of 320 individuals of Ashkenazi Jewish descent, detecting mutations in 78 individuals (carrier HET status), 19 more than had they screened only the ACMG-recommended mutations.